MiMedx Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDXG research report →
About the company
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue.
- CEO
- Joseph H. Capper
- IPO
- 2008
- Employees
- 837
- HQ
- Marietta, GA, US
Price Chart
- Market Cap
- $544.40M
- P/E
- 17.68
- P/S
- 1.40
- P/B
- 2.23
- EV/EBITDA
- 7.03
- Div Yield
- 0.00%
- Gross Margin
- 81.04%
- Op Margin
- 10.17%
- Net Margin
- 7.88%
- ROE
- 12.86%
- ROIC
- 10.81%
- Revenue
- $418.63M · 19.99%
- Net Income
- $48.58M · 14.52%
- EPS
- $0.33 · 13.79%
- Op Income
- $63.89M
- FCF YoY
- 13.11%
- 52W High
- $7.99
- 52W Low
- $3.03
- 50D MA
- $3.61
- 200D MA
- $5.50
- Beta
- 1.46
- Avg Volume
- 1.55M
Get TickerSpark's AI analysis on MDXG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | BIERMAN JAMES L | other | 50,913 |
| Jun 10, 26 | PUHY DOROTHY E | other | 50,913 |
| Jun 10, 26 | Newton Todd | other | 50,913 |
| Jun 10, 26 | HAWKINS WILLIAM A | other | 50,913 |
| Jun 10, 26 | Olson Tiffany | other | 50,913 |
| Mar 13, 26 | Hulse William Frank IV | other | 20,245 |
| Mar 13, 26 | Maersk-Moller Kimberly | other | 6,762 |
| Mar 10, 26 | Maersk-Moller Kimberly | other | 42,845 |
| Mar 10, 26 | Maersk-Moller Kimberly | other | 21,270 |
| Mar 10, 26 | Hulse William Frank IV | other | 136,364 |
Our MDXG coverage
Recent articles, reports, and earnings notes.
Want a deeper read on MDXG?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.